LONDON--(BUSINESS WIRE)--Ellipses Pharma Limited (“Ellipses”), a global drug development company focused on accelerating the development of new oncology treatments, will present a “Trial in Progress” ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback